Home›Companies›Consumer & Retail›NeuroReserve

NeuroReserve Inc.

NeuroReserve sells brain health nutritional supplements to consumers.

Updated Nov 18, 2026·Latest SEC filing Apr 9, 2025·Suggest an edit

About NeuroReserve

NeuroReserve is a private company based in Las Vegas, Nevada. It has reported $2,660,236 raised in five offerings on Form D since May 2019.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 24, 2025Apr 9, 2025$691,230fully sold5$138KEquity, Options, Securities on exerciseRule 506(b)Form D ↗
Aug 31, 2022Sep 12, 2022amended Dec 4, 2023$1,384,006of $1.5M target34$40,706EquityRule 506(b)Form D/A ↗1 earlier filing
Jul 15, 2021Sep 8, 2021$295,000of $350K target14$21,071Debt, OptionsRule 506(b)Form D ↗
Jul 22, 2020Aug 5, 2020$240,000of $475K target8$30,000Debt, OptionsRule 506(b)Form D ↗
Apr 30, 2019May 14, 2019$50,000of $125K target4$12,500Debt, OptionsRule 506(b)Form D ↗
Total, five offerings$2,660,236

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on NeuroReserve's Form D filed Apr 9, 2025.

Edward Park
Edward Park
Founder and director
On every Form D that NeuroReserve has filed: 6 filings, from May 14, 2019 to Apr 9, 2025.
RN
Robert Newell
Director
First appears on the Form D that NeuroReserve filed on September 12, 2022; on 3 of its 6 filings.

Sources

  1. SECNeuroReserve Inc. Form D, filed Sep 12, 2022
  2. SECNeuroReserve Inc. filing history
  3. CompanyTerms & Conditions
  4. CompanyAbout RELEVATE Brain Supplement
  5. CompanyMeet Your Team